Role of myocardial inflammation in the progression of Fabry cardiomyopathy: a multicentre cardiac magnetic resonance study

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Maria Alessandra Schiavo

IRCCS Sant'Orsola Polyclinic, Bologna (Italy)

7 More presentations in this session

Presentation thumbnail

Cardiovascular prognostic determinants in anderson-fabry disease: insights from a multicenter cohort study

Doctor Y. Chen (Shanghai, CN)

Abstract Slides Video

Presentation thumbnail

FollowME Fabry Pathfinders real-world registry in Spain and Portugal: cardiac and renal outcomes with migalastat in patients with Fabry disease

Professor O. Azevedo (Guimaraes, PT)

Abstract Slides Video

Presentation thumbnail

Apical hypertrophic cardiomyopathy: could it be Fabry?

Doctor S. Findlay (Cambridge, GB)

Abstract Slides Video

Presentation thumbnail

Prevalence of pseudo-delta wave in Anderson-Fabry disease and challenges in differentiating from ventricular pre-excitation

Doctor S. Serratore (Catanzaro, IT)

Abstract Slides Video

Presentation thumbnail

Fabry disease screening in patients with idiopathic HCM or idiopathic LVH: preliminary data from the multicentric nationwide F-CHECK study

Doctor E. Martins (Porto, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Fabry disease

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

T2 mapping as a marker of active myocardial injury in Anderson-Fabry disease patients

Congress Presentation

Cardiac magnetic resonance findings in Fabry disease

Congress Presentation

Imaging predictors of adverse prognosis in fabry disease cardiomyopathy: a systematic review and meta-analysis

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources